Getting more out of life
July 2010
David Rawson-Mackenzie, founder and managing director of Centurion Group, offers an overview of how life settlements work as an investment tool and how they can help to diversify an investment portfolio in July edition of International Adviser.

Striving for a secure life
July 2010
David Rawson-Mackenzie, founder and managing director of Centurion Group, comments on the progress to securitisation of life settlement policies in July edition of Financial Planner Magazine.

Centurion Fund Managers welcomes FSA's comments on the life settlements market
February 2010
The comments made by the Financial Services Authority (FSA) at the European Life Settlement Association conference emphasised the need for a transparent and sophisticated approach when taking life settlement funds to the market.
Centurion Fund Managers welcomes this approach as it supports our firmly held position that longevity is a complex asset class where the risks need to be responsibly managed by experienced fund managers and clearly understood by investors.

Centurion launches Defined Return Fund - Longevity Plus class
February 2010
Centurion Fund Managers announced that it will make available the Defined Return Fund Longevity Plus Class to High Net Worth investors. The fund has previously only been available to institutional investors. Professional investors will now have the opportunity to participate in a life settlement fund with 48 consecutive months of positive performance and an annualised return of 9.5% since inception.

Centurion launches first ever macro/micro longevity fund
December 2009
Centurion Fund Managers has obtained regulatory approval from the Commission de Surveillance du Secteur Financier (CSSF) in Luxembourg for its fourth open-ended longevity fund - which is the first in the market to combine macro and micro longevity. The professional investor fund - which is called the Centurion Longevity Fund - targets an annual return of 6-9% with low volatility and minimal correlation to the stock markets.

HFM Week
December 2009
As we begin to see a higher degree of transparency and convergence in life expectancy estimates, David Rawson-Mackenzie shows how life settlement funds can tailor their needs by using synthetics structured either as longevity or mortality notes.

Financial Adviser
November 2009
In this article, David Rawson-Mackenzie analysis longevity as an asset class. The article explains the difference between micro and macro longevity and it also reviews the key elements to have in mind when investing in this asset class.

International Advisor
November 2009
David Rawson-Mackenzie, director of Centurion Fund Managers, explains how to evaluate the risks in a life settlement fund. As with a lot of alternative investment funds, it is often difficult for outside investors to evaluate all the risks, and a life settlement fund is no exception. The article analyses the common risks associated to a life settlement fund and how Centurion mitigates them.

Life & Pensions
October 2009
The US life settlements sector is marketing itself to pension funds and European insurers as an easy way to add diversification to a portfolio. The article provides an overview of the asset class and its benefits for pension funds.

STORM
September 2009
David Rawson-Mackenzie, director of Centurion Fund Managers, was interviewed by STORM and explained how Centurion uses customised synthetic products to optimise its longevity funds and enhance liquidity management.

Investment Week
August 2009
The article explains why in life settlement funds, accurate valuation methodologies are needed to ensure fairness to all shareholders and to maintain sufficient liquidity. Successful fund managers in this asset class have developed solid valuation methodologies.

International Advisor
July 2009
David Rawson-Mackenzie examines how the recent rulings by the IRS have re-focused the spotlight on the thorny issue of the taxation of life settlements.

Investment Week
April 2009
An analysis of liquidity in life settlement funds which looks at the challenge of managing and generating liquidity in order to maintain performance.

Professional Wealth Management
March 2009
David Rawson-Mackenzie and Pollyanna Wan examine synthetic micro-longevity instruments as a longevity asset which is steadily gaining popularity as investors seek greater diversification

Bloomberg
March 2009
Report on the current market for life settlement policies.

Centurion undertakes its first leveraged longevity swap
July 2008
In a ground breaking transaction, Centurion Fund Managers has undertaken its first ever leveraged longevity swap in the life settlement market with Credit Suisse. The swap is constructed around the purchase of a portfolio of synthetic life policies, each designed to pay out a standard amount on variable dates.
The swap offers a number of key advantages to Centurion over the more traditional form of life settlements currently available in the market.